These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 18205176)

  • 1. Remodeling of motor nerve terminals in demyelinating axons of periaxin-null mice.
    Court FA; Brophy PJ; Ribchester RR
    Glia; 2008 Mar; 56(4):471-9. PubMed ID: 18205176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The function of the Periaxin gene during nerve repair in a model of CMT4F.
    Williams AC; Brophy PJ
    J Anat; 2002 Apr; 200(4):323-30. PubMed ID: 12090399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease.
    Niemann A; Berger P; Suter U
    Neuromolecular Med; 2006; 8(1-2):217-42. PubMed ID: 16775378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteolipid protein modulates preservation of peripheral axons and premature death when myelin protein zero is lacking.
    Patzig J; Kusch K; Fledrich R; Eichel MA; Lüders KA; Möbius W; Sereda MW; Nave KA; Martini R; Werner HB
    Glia; 2016 Jan; 64(1):155-74. PubMed ID: 26393339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged high frequency electrical stimulation is lethal to motor axons of mice heterozygously deficient for the myelin protein P₀ gene.
    Alvarez S; Moldovan M; Krarup C
    Exp Neurol; 2013 Sep; 247():552-61. PubMed ID: 23439028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelin abnormality in Charcot-Marie-Tooth type 4J recapitulates features of acquired demyelination.
    Hu B; McCollum M; Ravi V; Arpag S; Moiseev D; Castoro R; Mobley B; Burnette B; Siskind C; Day J; Yawn R; Feely S; Li Y; Yan Q; Shy M; Li J
    Ann Neurol; 2018 Apr; 83(4):756-770. PubMed ID: 29518270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromuscular Junction Changes in a Mouse Model of Charcot-Marie-Tooth Disease Type 4C.
    Cipriani S; Phan V; Médard JJ; Horvath R; Lochmüller H; Chrast R; Roos A; Spendiff S
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30562927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelin is dependent on the Charcot-Marie-Tooth Type 4H disease culprit protein FRABIN/FGD4 in Schwann cells.
    Horn M; Baumann R; Pereira JA; Sidiropoulos PN; Somandin C; Welzl H; Stendel C; Lühmann T; Wessig C; Toyka KV; Relvas JB; Senderek J; Suter U
    Brain; 2012 Dec; 135(Pt 12):3567-83. PubMed ID: 23171661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schwann Cell O-GlcNAc Glycosylation Is Required for Myelin Maintenance and Axon Integrity.
    Kim S; Maynard JC; Sasaki Y; Strickland A; Sherman DL; Brophy PJ; Burlingame AL; Milbrandt J
    J Neurosci; 2016 Sep; 36(37):9633-46. PubMed ID: 27629714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelin protein zero gene dose dependent axonal ion-channel dysfunction in a family with Charcot-Marie-Tooth disease.
    Moldovan M; Pisciotta C; Pareyson D; Krarup C
    Clin Neurophysiol; 2020 Oct; 131(10):2440-2451. PubMed ID: 32829291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MpzR98C arrests Schwann cell development in a mouse model of early-onset Charcot-Marie-Tooth disease type 1B.
    Saporta MA; Shy BR; Patzko A; Bai Y; Pennuto M; Ferri C; Tinelli E; Saveri P; Kirschner D; Crowther M; Southwood C; Wu X; Gow A; Feltri ML; Wrabetz L; Shy ME
    Brain; 2012 Jul; 135(Pt 7):2032-47. PubMed ID: 22689911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterozygous peripheral myelin protein 22-deficient mice are affected by a progressive demyelinating tomaculous neuropathy.
    Adlkofer K; Frei R; Neuberg DH; Zielasek J; Toyka KV; Suter U
    J Neurosci; 1997 Jun; 17(12):4662-71. PubMed ID: 9169527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rat model of Charcot-Marie-Tooth disease 1A recapitulates disease variability and supplies biomarkers of axonal loss in patients.
    Fledrich R; Schlotter-Weigel B; Schnizer TJ; Wichert SP; Stassart RM; Meyer zu Hörste G; Klink A; Weiss BG; Haag U; Walter MC; Rautenstrauss B; Paulus W; Rossner MJ; Sereda MW
    Brain; 2012 Jan; 135(Pt 1):72-87. PubMed ID: 22189569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early abnormalities in sciatic nerve function and structure in a rat model of Charcot-Marie-Tooth type 1A disease.
    Grandis M; Leandri M; Vigo T; Cilli M; Sereda MW; Gherardi G; Benedetti L; Mancardi G; Abbruzzese M; Nave KA; Nobbio L; Schenone A
    Exp Neurol; 2004 Nov; 190(1):213-23. PubMed ID: 15473994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C1orf194 deficiency leads to incomplete early embryonic lethality and dominant intermediate Charcot-Marie-Tooth disease in a knockout mouse model.
    Huang C; Shen ZR; Huang J; Sun SC; Ma D; Li MY; Wang ZK; Zheng YC; Zheng ZJ; He F; Xu X; Li Z; Zheng BY; Li YM; Xu XM; Xiong F
    Hum Mol Genet; 2020 Aug; 29(15):2471-2480. PubMed ID: 32592472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients.
    Hattori N; Yamamoto M; Yoshihara T; Koike H; Nakagawa M; Yoshikawa H; Ohnishi A; Hayasaka K; Onodera O; Baba M; Yasuda H; Saito T; Nakashima K; Kira J; Kaji R; Oka N; Sobue G;
    Brain; 2003 Jan; 126(Pt 1):134-51. PubMed ID: 12477701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nerve conduction abnormalities in aging mice deficient for myelin-associated glycoprotein.
    Weiss MD; Luciano CA; Quarles RH
    Muscle Nerve; 2001 Oct; 24(10):1380-7. PubMed ID: 11562920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synaptic Deficits at Neuromuscular Junctions in Two Mouse Models of Charcot-Marie-Tooth Type 2d.
    Spaulding EL; Sleigh JN; Morelli KH; Pinter MJ; Burgess RW; Seburn KL
    J Neurosci; 2016 Mar; 36(11):3254-67. PubMed ID: 26985035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mutation in periaxin is responsible for CMT4F, an autosomal recessive form of Charcot-Marie-Tooth disease.
    Guilbot A; Williams A; Ravisé N; Verny C; Brice A; Sherman DL; Brophy PJ; LeGuern E; Delague V; Bareil C; Mégarbané A; Claustres M
    Hum Mol Genet; 2001 Feb; 10(4):415-21. PubMed ID: 11157804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Axonal domain disorganization in Caspr1 and Caspr2 mutant myelinated axons affects neuromuscular junction integrity, leading to muscle atrophy.
    Saifetiarova J; Liu X; Taylor AM; Li J; Bhat MA
    J Neurosci Res; 2017 Jul; 95(7):1373-1390. PubMed ID: 28370195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.